Christine Born Selected Research

Aftercare (After-Treatment)

4/2009

Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christine Born Research Topics

Disease

3	Alzheimer Disease (Alzheimer's Disease) 03/2016 - 04/2009
2	Cognitive Dysfunction 03/2016 - 06/2010
1	Prodromal Symptoms 03/2016
1	Panic Disorder (Panic Attack) 02/2009
1	Autosomal Recessive 3 Severe Congenital Neutropenia 02/2007
1	1 Rippling muscle disease 07/2006
1	Distal Myopathies (Distal Muscular Dystrophy) 07/2006
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 07/2006
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 07/2006
1	Esophageal Fistula 09/2003

Drug/Important Bio-Agent (IBA)

1	Rivastigmine (Exelon)FDA LinkGeneric 03/2016
1	Cholinergic Agents (Cholinergics)IBA 03/2016
1	Biomarkers (Surrogate Marker)IBA 06/2010
1	Apolipoprotein E4IBA 06/2010
1	Galantamine (Galanthamine)FDA LinkGeneric 04/2009
1	TetragastrinIBA 02/2009
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2007
1	Proteins (Proteins, Gene)FDA Link 07/2006
1	Caveolin 3IBA 07/2006
1	allogenic effect factor (AEF)IBA 09/2003

Therapy/Procedure

1	Aftercare (After-Treatment) 04/2009
1	Laparotomy 09/2003